4//SEC Filing
Venrock Associates VI, L.P. 4
Accession 0001495384-19-000002
CIK 0001770787other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:28 PM ET
Size
15.9 KB
Accession
0001495384-19-000002
Insider Transaction Report
Form 4
Venrock Associates VI, L.P.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-09-16−3,272,171→ 0 total(indirect: By Funds)→ Class B Common Stock (3,272,171 underlying) - Conversion
Series A-2 Preferred Stock
2019-09-16−7,819,645→ 0 total(indirect: By Funds)→ Class B Common Stock (7,819,645 underlying) - Conversion
Class B Common Stock
2019-09-16+11,091,816→ 11,091,816 total(indirect: By Funds)→ Class A Common Stock (11,091,816 underlying)
Venrock Management VI, LLC
10% Owner
Transactions
- Conversion
Class B Common Stock
2019-09-16+11,091,816→ 11,091,816 total(indirect: By Funds)→ Class A Common Stock (11,091,816 underlying) - Conversion
Series A-2 Preferred Stock
2019-09-16−7,819,645→ 0 total(indirect: By Funds)→ Class B Common Stock (7,819,645 underlying) - Conversion
Series B Preferred Stock
2019-09-16−3,272,171→ 0 total(indirect: By Funds)→ Class B Common Stock (3,272,171 underlying)
Venrock Partners Management VI, LLC
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-09-16−3,272,171→ 0 total(indirect: By Funds)→ Class B Common Stock (3,272,171 underlying) - Conversion
Series A-2 Preferred Stock
2019-09-16−7,819,645→ 0 total(indirect: By Funds)→ Class B Common Stock (7,819,645 underlying) - Conversion
Class B Common Stock
2019-09-16+11,091,816→ 11,091,816 total(indirect: By Funds)→ Class A Common Stock (11,091,816 underlying)
Venrock Partners VI, L.P.
10% Owner
Transactions
- Conversion
Series A-2 Preferred Stock
2019-09-16−7,819,645→ 0 total(indirect: By Funds)→ Class B Common Stock (7,819,645 underlying) - Conversion
Series B Preferred Stock
2019-09-16−3,272,171→ 0 total(indirect: By Funds)→ Class B Common Stock (3,272,171 underlying) - Conversion
Class B Common Stock
2019-09-16+11,091,816→ 11,091,816 total(indirect: By Funds)→ Class A Common Stock (11,091,816 underlying)
Footnotes (3)
- [F1]The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date. Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation.
- [F2]Represents (a) 7,250,375 shares of Class B common stock held by Venrock Associates VI, L.P. ("VA VI") and (b) 569,270 shares of Class B common stock held by Venrock Partners VI, L.P. ("VP VI"). Venrock Management VI, LLC ("VM VI"), is the sole general partner of VA VI. Venrock Partners Management VI, LLC ("VPM VI"), is the sole general partner of VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein.
- [F3]Represents (a) 3,033,957 shares of Class B common stock held by VA VI and (b) 238,214 shares of Class B common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001495384
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 5:28 PM ET
- Size
- 15.9 KB